✦ LIBER ✦

Protocol development for combination therapy with disease-modifying antirheumatic drugs

✍ Scribed by Harold E. Paulus

Book ID: 114098445
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 774 KB
Volume: 23
Category: Article
ISSN: 0049-0172
DOI: 10.1016/s0049-0172(10)80004-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacotherapeutic combination strategi

Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis

✍ Piet L.C.M. van Riel; Cees J. Haagsma; Daniel E. Furst 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Interleukin-6 receptor inhibition with t

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Leflunomide combined with conventional d

Leflunomide combined with conventional disease-modifying antirheumatic drugs or biologics in patients with rheumatoid arthritis

✍ Bernard Combe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Renal toxicity associated with disease-m

Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis

✍ Michael H. Schiff; Andrew Whelton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Etanercept in combination with conventio

Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate

✍ Yoshinobu Koyama; Hirokazu Shiraishi; Toshiyuki Ohta; Ayumi Uchino 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 350 KB

The good initial response to therapy wit

The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial

✍ Vappu Rantalaiho; Markku Korpela; Pekka Hannonen; Hannu Kautiainen; Salme Järven 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views